Vaxart’s pills Vaxart
THE race to develop vaccines against covid-19 got off to a flyer, but with dangerous new virus variants, stark inequalities in access to vaccines and few vaccination options for children, the world still needs all hands on deck. Last week, a virtual meeting run by the New York Academy of Sciences called showcased the most promising new candidates.
Codagenix: Nose drop
So far, all approved covid-19 vaccines have been injectable. Another option is a nose drop, says Robert Coleman, CEO of biotech company , in Farmingdale, New York.
Codagenix’s technology…
Article amended on 12 February 2021
We corrected the delivery mechanism of the Codagenix vaccine candidate
